- Home
- OCEA vs SPCB Comparison
OCEA vs SPCB Comparison
Compare OCEA & SPCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCEA
- SPCB
- Stock Information
- Founded
- OCEA 2019
- SPCB 1988
- Country
- OCEA United States
- SPCB Israel
- Employees
- OCEA N/A
- SPCB N/A
- Industry
- OCEA Biotechnology: Pharmaceutical Preparations
- SPCB Semiconductors
- Sector
- OCEA Health Care
- SPCB Technology
- Exchange
- OCEA Nasdaq
- SPCB Nasdaq
- Market Cap
- OCEA 20.5M
- SPCB 19.2M
- IPO Year
- OCEA N/A
- SPCB N/A
- Fundamental
- Price
- OCEA $0.54
- SPCB $13.42
- Analyst Decision
- OCEA
- SPCB
- Analyst Count
- OCEA 0
- SPCB 0
- Target Price
- OCEA N/A
- SPCB N/A
- AVG Volume (30 Days)
- OCEA 617.7K
- SPCB 3.0M
- Earning Date
- OCEA 01-13-2025
- SPCB 11-14-2024
- Dividend Yield
- OCEA N/A
- SPCB N/A
- EPS Growth
- OCEA N/A
- SPCB N/A
- EPS
- OCEA N/A
- SPCB 1.02
- Revenue
- OCEA N/A
- SPCB $26,843,000.00
- Revenue This Year
- OCEA N/A
- SPCB $6.72
- Revenue Next Year
- OCEA N/A
- SPCB $15.83
- P/E Ratio
- OCEA N/A
- SPCB $13.15
- Revenue Growth
- OCEA N/A
- SPCB 5.23
- 52 Week Low
- OCEA $0.46
- SPCB $2.55
- 52 Week High
- OCEA $7.79
- SPCB $13.49
- Technical
- Relative Strength Index (RSI)
- OCEA 40.01
- SPCB 78.09
- Support Level
- OCEA $0.53
- SPCB $7.84
- Resistance Level
- OCEA $0.70
- SPCB $10.05
- Average True Range (ATR)
- OCEA 0.08
- SPCB 2.29
- MACD
- OCEA -0.00
- SPCB 0.54
- Stochastic Oscillator
- OCEA 4.31
- SPCB 99.29
About OCEA Ocean Biomedical Inc.
Ocean Biomedical Inc is a biopharmaceutical company that is focused on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases. The company is developing an antibody therapeutic product candidate inhibiting Chi3l1, and a bi-specific antibody product candidate inhibiting Chi3l1 plus PD-1 and CTLA-4 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome.
About SPCB SuperCom Ltd. (Israel)
SuperCom Ltd is an Israel-based provider of traditional and digital identity solutions, providing safety, identification, tracking, and security products to governments and organizations. The company comprises three main Strategic Business Units: e-Gov; IoT and Connectivity, which is the key revenue driver; and Cyber Security. Besides, it also offers a wide range of solutions that include national ID registries, e-passports, biometric visas, automated fingerprint identification systems, digitized driver's licenses, and electronic voter registration and election management using the common platform. The geographical segments of the company include Africa, European countries, South America, the United States, Israel, and the Asia Pacific.